Loading…

Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device

The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of artificial organs 2017-06, Vol.20 (2), p.170-173
Main Authors: Nakamura, Yuki, Toda, Koichi, Nakamura, Teruya, Miyagawa, Shigeru, Yoshikawa, Yasushi, Fukushima, Satsuki, Saito, Shunsuke, Yoshioka, Daisuke, Domae, Keitaro, Takahashi, Tsuyoshi, Hashimoto, Tadayoshi, Doki, Yuichiro, Sawa, Yoshiki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an LVAD is estimated to increase. In patients with LVADs, abdominal surgery for visceral malignancy is associated with technical difficulties because of the presence of an LVAD pump or the driveline which is located transversely in the preperitoneal space. Herein, we describe the technical management for complete resection of gastric cancer in a patient with an LVAD.
ISSN:1434-7229
1619-0904
DOI:10.1007/s10047-016-0944-3